Mikael Kubista

CEO at TATAA Biocenter, Prof. at BTU, CAS

In 1996 Kubista invented the light-up probes, which led to the foundation of LightUp Technologies AB as Europe´s first company focusing on qPCR based diagnostics. He co-founded MultiD Analyses AB, which develops the market leading software GenEx for molecular analysis, and in 2001 Kubista set up TATAA Biocenter as the first laboratory in Europe to obtain flexible ISO 17025 accreditation.

TATAA Biocenter was named “Best Nucleic Acid Analysis Service Provider – Europe” by Global Health & Pharma in 2019 and is member of the SPIDIA4P consortium developing international standards for the preanalytical process in molecular diagnostic and the IMI CANCER-ID consortium standardizing liquid biopsy testing for the pharmaceutical industry. Kubista introduced non-invasive prenatal testing (NIPT) in Sweden founding Life Genomics AB and Gendoktorn, and direct blood genotyping co-founding LifeTest. Most recently Kubista’s team invented Two-tailed PCR for ultrasensitive profiling of circulating microRNAs.


Title: Two-Tailed PCR for Precision Diagnostic

  • Two-Tailed PCR
  • Ultra-sensitive microRNA profiling
  • Ultra-specific rare mutation analysis
  • Quality assessment of liquid biopsy testing